Get the Stockscreener App
42.08
1.02%
-0.3014
Overview
News
Price History
Option Chain
Financials
Why NKE Down?
Discussions
Forecast
Stock Split
Dividend History
Nike Inc stock is traded at $42.08, with a volume of 12.28M.
It is down -1.02% in the last 24 hours and down -6.09% over the past month.
Nike is the largest athletic footwear and apparel brand in the world. Footwear generates about two-thirds of its sales. Key performance footwear categories include basketball, running, and football (soccer). Its brands include Nike, Jordan (premium athletic footwear and clothing), NikeSkims (women's athleisure), and Converse (casual footwear). Nike sells products worldwide through company-owned stores, franchised stores (including about 5,500 in China), and third-party retailers. The firm also operates e-commerce platforms in more than 40 countries. Nearly all its production is outsourced to contract manufacturers in more than 30 countries. Nike was founded in 1964 and is based in Beaverton, Oregon.
See More
Previous Close:
$42.38
Open:
$42.035
24h Volume:
12.28M
Relative Volume:
0.53
Market Cap:
$62.28B
Revenue:
$46.55B
Net Income/Loss:
$2.25B
P/E Ratio:
27.68
EPS:
1.5202
Net Cash Flow:
$1.05B
1W Performance:
-5.07%
1M Performance:
-6.09%
6M Performance:
-30.09%
1Y Performance:
-31.70%
1-Day Range:
$41.31
$42.33
1-Week Range:
$41.31
$45.70
52-Week Range:
$41.31
$80.17
Nike Inc Stock (NKE) Company Profile
Name
Nike Inc
Sector
Industry
Phone
(503) 671-3173
Address
ONE BOWERMAN DR, BEAVERTON, OR
Compare NKE vs DECK, ONON, BIRK, CROX
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NKE
Nike Inc
|
42.05 | 62.76B | 46.55B | 2.25B | 1.05B | 1.5202 |
DECK
Deckers Outdoor Corp
|
106.79 | 14.39B | 5.45B | 1.02B | 1.10B | 7.0391 |
ONON
On Holding Ag
|
36.67 | 11.71B | 3.89B | 317.40M | 361.55M | 0.9463 |
BIRK
Birkenstock Holding Plc
|
44.84 | 7.79B | 2.53B | 410.81M | 291.40M | 2.2229 |
CROX
Crocs Inc
|
121.57 | 6.02B | 4.02B | -103.75M | 642.88M | -1.3787 |
Nike Inc Stock (NKE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-13-26 | Downgrade | HSBC Securities | Buy → Hold |
| Apr-10-26 | Downgrade | Piper Sandler | Overweight → Neutral |
| Apr-01-26 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-01-26 | Downgrade | Goldman | Buy → Neutral |
| Apr-01-26 | Downgrade | JP Morgan | Overweight → Neutral |
| Mar-25-26 | Reiterated | Telsey Advisory Group | Market Perform |
| Mar-11-26 | Upgrade | Barclays | Equal Weight → Overweight |
| Jan-08-26 | Initiated | Deutsche Bank | Hold |
| Jan-08-26 | Downgrade | Needham | Buy → Hold |
| Dec-19-25 | Reiterated | Needham | Buy |
| Dec-19-25 | Reiterated | Telsey Advisory Group | Market Perform |
| Dec-10-25 | Initiated | Guggenheim | Buy |
| Nov-13-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Oct-15-25 | Initiated | BTIG Research | Buy |
| Oct-02-25 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Sep-23-25 | Reiterated | Telsey Advisory Group | Market Perform |
| Sep-18-25 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Sep-10-25 | Upgrade | TD Cowen | Hold → Buy |
| Jul-28-25 | Upgrade | JP Morgan | Neutral → Overweight |
| Jul-10-25 | Downgrade | DZ Bank | Buy → Hold |
| Jul-01-25 | Upgrade | Argus | Hold → Buy |
| Jun-27-25 | Upgrade | HSBC Securities | Hold → Buy |
| Jun-27-25 | Reiterated | Needham | Buy |
| Jun-18-25 | Reiterated | Needham | Buy |
| May-06-25 | Reiterated | Telsey Advisory Group | Market Perform |
| Apr-30-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-15-25 | Initiated | Berenberg | Hold |
| Mar-21-25 | Reiterated | Needham | Buy |
| Mar-19-25 | Initiated | China Renaissance | Hold |
| Feb-24-25 | Upgrade | Jefferies | Hold → Buy |
| Feb-07-25 | Downgrade | Citigroup | Buy → Neutral |
| Jan-10-25 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-20-24 | Downgrade | Telsey Advisory Group | Outperform → Market Perform |
| Dec-16-24 | Reiterated | Telsey Advisory Group | Outperform |
| Dec-16-24 | Reiterated | Wells Fargo | Overweight |
| Nov-22-24 | Initiated | Needham | Buy |
| Oct-10-24 | Upgrade | Truist | Hold → Buy |
| Oct-02-24 | Reiterated | Telsey Advisory Group | Outperform |
| Aug-23-24 | Resumed | Piper Sandler | Neutral |
| Jul-02-24 | Reiterated | RBC Capital Mkts | Sector Perform |
| Jun-28-24 | Downgrade | Barclays | Overweight → Equal Weight |
| Jun-28-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Jun-28-24 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jun-28-24 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jun-28-24 | Downgrade | Stifel | Buy → Hold |
| Jun-28-24 | Reiterated | Telsey Advisory Group | Outperform |
| Jun-28-24 | Downgrade | UBS | Buy → Neutral |
| Jun-21-24 | Upgrade | Oppenheimer | Perform → Outperform |
| Jun-13-24 | Resumed | Deutsche Bank | Buy |
| Apr-11-24 | Upgrade | BofA Securities | Neutral → Buy |
| Mar-22-24 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Mar-22-24 | Reiterated | Telsey Advisory Group | Outperform |
| Mar-18-24 | Reiterated | Telsey Advisory Group | Outperform |
| Feb-16-24 | Downgrade | Oppenheimer | Outperform → Perform |
| Jan-22-24 | Reiterated | HSBC Securities | Hold |
| Dec-22-23 | Downgrade | TD Cowen | Outperform → Market Perform |
| Dec-15-23 | Reiterated | Telsey Advisory Group | Outperform |
| Dec-14-23 | Reiterated | RBC Capital Mkts | Outperform |
| Dec-12-23 | Upgrade | DZ Bank | Hold → Buy |
| Dec-11-23 | Upgrade | Citigroup | Neutral → Buy |
| Dec-05-23 | Resumed | Goldman | Buy |
| Nov-17-23 | Initiated | Truist | Hold |
| Nov-07-23 | Initiated | Evercore ISI | Outperform |
| Sep-25-23 | Downgrade | Jefferies | Buy → Hold |
| Sep-18-23 | Reiterated | HSBC Securities | Hold |
| Sep-18-23 | Reiterated | Wells Fargo | Overweight |
| Aug-28-23 | Reiterated | Stifel | Buy |
| Jul-25-23 | Downgrade | Exane BNP Paribas | Neutral → Underperform |
| Jul-25-23 | Resumed | KeyBanc Capital Markets | Sector Weight |
| Jul-03-23 | Reiterated | Morgan Stanley | Overweight |
| Jul-03-23 | Reiterated | Robert W. Baird | Outperform |
| Mar-22-23 | Upgrade | Barclays | Equal Weight → Overweight |
| Mar-16-23 | Initiated | Redburn | Sell |
| Dec-14-22 | Reiterated | Telsey Advisory Group | Outperform |
| Oct-13-22 | Initiated | Raymond James | Outperform |
| Oct-03-22 | Downgrade | Argus | Buy → Hold |
| Sep-30-22 | Reiterated | BofA Securities | Neutral |
| Sep-30-22 | Reiterated | Citigroup | Neutral |
| Sep-30-22 | Reiterated | Cowen | Outperform |
| Sep-30-22 | Reiterated | Credit Suisse | Outperform |
| Sep-30-22 | Reiterated | Deutsche Bank | Buy |
| Sep-30-22 | Reiterated | Guggenheim | Buy |
| Sep-30-22 | Reiterated | JP Morgan | Overweight |
| Sep-30-22 | Reiterated | Jefferies | Buy |
| Sep-30-22 | Reiterated | Morgan Stanley | Overweight |
| Sep-30-22 | Reiterated | Piper Sandler | Neutral |
| Sep-30-22 | Reiterated | RBC Capital Mkts | Outperform |
| Sep-30-22 | Reiterated | Stifel | Buy |
| Sep-30-22 | Reiterated | Telsey Advisory Group | Outperform |
| Sep-30-22 | Reiterated | UBS | Buy |
| Sep-26-22 | Reiterated | Telsey Advisory Group | Outperform |
| Sep-22-22 | Initiated | RBC Capital Mkts | Outperform |
| Sep-20-22 | Downgrade | Barclays | Overweight → Equal Weight |
| Jun-22-22 | Downgrade | Seaport Research Partners | Buy → Neutral |
| Jun-22-22 | Reiterated | Telsey Advisory Group | Outperform |
| Jun-15-22 | Resumed | Morgan Stanley | Overweight |
| Mar-15-22 | Initiated | Bernstein | Outperform |
| Jan-25-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-18-22 | Initiated | Seaport Research Partners | Buy |
| Jan-10-22 | Downgrade | HSBC Securities | Buy → Hold |
| Dec-16-21 | Reiterated | Telsey Advisory Group | Outperform |
| Dec-16-21 | Initiated | Truist | Buy |
| Dec-15-21 | Resumed | Wells Fargo | Equal Weight |
| Oct-12-21 | Initiated | Goldman | Buy |
| Oct-05-21 | Initiated | Wedbush | Outperform |
| Sep-27-21 | Reiterated | Barclays | Overweight |
| Sep-13-21 | Downgrade | BTIG Research | Buy → Neutral |
| Jun-25-21 | Reiterated | BMO Capital Markets | Outperform |
| Jun-25-21 | Reiterated | BTIG Research | Buy |
| Jun-25-21 | Reiterated | BofA Securities | Neutral |
| Jun-25-21 | Reiterated | Credit Suisse | Outperform |
| Jun-25-21 | Reiterated | Deutsche Bank | Buy |
| Jun-25-21 | Reiterated | Guggenheim | Buy |
| Jun-25-21 | Reiterated | Jefferies | Buy |
| Jun-25-21 | Reiterated | Pivotal Research Group | Buy |
| Jun-25-21 | Reiterated | RBC Capital Mkts | Outperform |
| Jun-25-21 | Reiterated | Robert W. Baird | Outperform |
| Jun-25-21 | Reiterated | Stifel | Buy |
| Jun-25-21 | Reiterated | Telsey Advisory Group | Outperform |
| Jun-25-21 | Reiterated | UBS | Buy |
| May-13-21 | Resumed | BofA Securities | Neutral |
| May-11-21 | Upgrade | Jefferies | Hold → Buy |
| Apr-23-21 | Resumed | RBC Capital Mkts | Outperform |
| Apr-20-21 | Downgrade | Citigroup | Buy → Neutral |
| Mar-26-21 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Mar-16-21 | Reiterated | Pivotal Research Group | Buy |
| Feb-25-21 | Upgrade | HSBC Securities | Hold → Buy |
| Dec-21-20 | Reiterated | Telsey Advisory Group | Outperform |
| Dec-11-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Nov-12-20 | Initiated | RBC Capital Mkts | Outperform |
| Sep-23-20 | Reiterated | BTIG Research | Buy |
| Sep-23-20 | Reiterated | Citigroup | Buy |
| Sep-23-20 | Reiterated | Credit Suisse | Outperform |
| Sep-23-20 | Upgrade | Deutsche Bank | Hold → Buy |
| Sep-23-20 | Reiterated | Goldman | Buy |
| Sep-23-20 | Reiterated | Guggenheim | Buy |
| Sep-23-20 | Reiterated | Morgan Stanley | Overweight |
| Sep-23-20 | Reiterated | Needham | Buy |
| Sep-23-20 | Reiterated | Piper Sandler | Overweight |
| Sep-23-20 | Reiterated | Pivotal Research Group | Buy |
| Sep-23-20 | Reiterated | Raymond James | Outperform |
| Sep-23-20 | Reiterated | Stifel | Buy |
| Sep-23-20 | Reiterated | Susquehanna | Positive |
| Sep-23-20 | Reiterated | Telsey Advisory Group | Outperform |
| Sep-23-20 | Reiterated | UBS | Buy |
| Sep-23-20 | Reiterated | Wedbush | Outperform |
| Sep-23-20 | Reiterated | Wells Fargo | Overweight |
View All
Nike Inc Stock (NKE) Latest News
Nike names Pfizer CFO David Denton to replace Matthew Friend - qz.com
Nike hires Pfizer's David Denton to take over for departing CFO - Moneycontrol.com
Nike’s New CFO Isn’t a Retail Insider—He’s Coming From Pfizer - Barron's
NIKE INC : Receives a Buy rating from Bernstein - marketscreener.com
Nike recruits its new chief financial officer from Pfizer - marketscreener.com
Rockefeller Capital Management L.P. Sells 47,694 Shares of NIKE, Inc. $NKE - MarketBeat
Nike names new chief financial officer - fashionunited.uk
Nike appoints new CFO amid troubled turnaround - Drapers
Nike Names Pfizer's David Denton CFO, Succeeding Matthew Friend; Sees Q4 To Include Tariff Benefit - RTTNews
NIKE, Inc. Announces Executive Transition and New Leadership Agreement – June 2026 - Minichart
Is Nike Inc (NKE) Positioned for Growth With Q4 Earnings Expecte - GuruFocus
Nike appoints new CFO - FashionNetwork France
NIKE, Inc. Announces Planned CFO Transition - afp.com
Nike (NKE) Names David Denton CFO As Turnaround Pressure Builds - Yahoo Finance
NKE Stock Gains 2% After-Hours — Nike Names New CFO And Reaffirms Outlook - Stocktwits
Nike names Pfizer executive David Denton as CFO amid slow turnaround effort - Reuters
Nike (NKE) Announces CFO Transition as Shares Rise - GuruFocus
Nike Announces New CFO and Finance Leadership Transition - TipRanks
Nike Discloses CFO Transition - WWD
Nike Hires Pfizer's Denton to Take Over for Departing CFO - Bloomberg.com
Nike, Inc. Taps Pfizer CFO to Fill its CFO Role as Matthew Friend Plans Departure - SGB Media Online
Nike names David Denton as CFO effective August 17 - Investing.com
Nike Names Pfizer Exec David Denton as Next CFO - Shop Eat Surf Outdoor
Nike Names New CFO as Turnaround Stumbles - Global Finance Magazine
Nike (NKE) Rises Following Appointment of New CFO - GuruFocus
NIKE (NKE) Welcomes New CFO David M. Denton - GuruFocus
Nike Names Pfizer’s Denton as Next CFO - WSJ
Nike stock rises on CFO transition and tariff refund benefit - Investing.com
Form 8K Nike For: 23 June By Investing.com - Investing.com Canada
Nike picks Denton to succeed Friend as CFO - Breakingthenews.net
Nike taps Pfizer executive David Denton to replace Matthew Friend (NKE:NYSE) - Seeking Alpha
Nike, Inc. Announces Executive Changes, Effective August 16, 2026 - marketscreener.com
New Nike (NYSE: NKE) CFO package includes $7.25M cash and rich incentives - Stock Titan
OR-NIKE - Voice of Alexandria
Nike Shares Fall After Evercore ISI Downgrade - marketscreener.com
Nike faces fresh downgrade from Evercore, shares trade lower ahead of earnings - AD HOC NEWS
Track and field: Burlington's Hill earns All-America honor at Nike Nationals - Daily Gate City
NIKE, Inc. Announces Planned CFO Transition — - About Nike
Marino, Lachino compete at Nike Nationals - Porterville Recorder
Jim Cramer on NIKE: “I’m Going to Give the Company One More Quarter” - Insider Monkey
Nike (NKE) Downgraded to In-Line Amid Challenges and Delays - GuruFocus
A big battleship to turn: Evercore downgrades Nike to In-Line (NKE:NYSE) - Seeking Alpha
Nike (NKE) Stock Falls as Evercore Sounds Alarm on Deepening Challenges - Blockonomi
How Will Nike Stock React To Its Upcoming Earnings? - Trefis
Nike Likely To Report Lower Q4 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call - Benzinga
NIKE INC : Goldman Sachs remains Neutral - marketscreener.com
Goldman Sachs Adjusts Price Target on NIKE to $46 From $52, Maintains Neutral Rating - marketscreener.com
SG Americas Securities LLC Acquires 167,301 Shares of NIKE, Inc. $NKE - MarketBeat
Nike prepares for Q4 earnings next week, analyst consensus and shares under pressure - AD HOC NEWS
NIKE (NKE) to Post Quarterly Earnings on Tuesday - MarketBeat
Does John Rogers’ Board Exit Reframe Nike’s (NKE) Turnaround and Brand Strategy Priorities? - Yahoo Finance
Nike Inc Stock (NKE) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.20%
0.89%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):